Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: 360iResearch | PRODUCT CODE: 1471350

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1471350

Urokinase Market by Type (Urokinase Powder, Urokinase Solution), Dose Strength (250000 Unit, 5000 Unit), Indication, Application - Global Forecast 2024-2030

PUBLISHED:
PAGES: 182 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF, Excel & Online Access - 1 Year (Single User License)
USD 4749
PDF, Excel & Online Access - 1 Year (Up to 5 User License)
USD 5749
PDF, Excel & Online Access - 1 Year (Site License)
USD 6749
PDF, Excel & Online Access - 1 Year (Enterprise User License)
USD 8749

Add to Cart

Description

Table of Contents

List of Tables

[182 Pages Report] The Urokinase Market size was estimated at USD 1.76 billion in 2023 and expected to reach USD 1.85 billion in 2024, at a CAGR 5.30% to reach USD 2.52 billion by 2030.

Urokinase is a type of enzyme, specifically a serine protease, produced in the kidneys and found in the urine. Urokinase plays a crucial role in the body's process of breaking down blood clots, making it an essential therapeutic agent in treating severe or life-threatening blood clotting conditions such as pulmonary embolism, coronary artery thrombosis, and certain types of stroke. The increased prevalence of these cardiovascular diseases and stroke globally has significantly expanded the use of urokinase as an effective treatment option. This trend is driven by an aging population, lifestyle factors, and the rising incidence of obesity, all of which contribute to the higher occurrence of thrombotic conditions. However, patients may experience side effects such as bleeding, allergic reactions, and other potential risks. However, the market for urokinase presents several opportunities for growth and expansion. Advances in biotechnology may lead to the production of more efficient and safer forms of urokinase, expanding its use into new therapeutic areas. Additionally, the increasing global healthcare expenditure and a better understanding of the conditions treated with urokinase are expected to further drive demand. There is also potential for developing novel drug delivery systems that could enhance the effectiveness and ease of use of urokinase-based treatments, thereby improving patient outcomes. As such, the urokinase market is positioned for sustained growth fueled by technological advancements, increased disease prevalence, and ongoing research efforts.

KEY MARKET STATISTICS
Base Year [2023] USD 1.76 billion
Estimated Year [2024] USD 1.85 billion
Forecast Year [2030] USD 2.52 billion
CAGR (%) 5.30%

Type: Significant preference towards urokinase powder due to superior shelf life

Urokinase powder is a lyophilized (freeze-dried) form of the enzyme, requiring reconstitution before administration to patients. This form is particularly favored for its extended shelf life and stability, making it a preferred option in settings where immediate use is not a necessity. The reconstitution process, however, requires careful handling to ensure the medication is prepared correctly for safe and effective use. On the other hand, urokinase solution is available in a liquid form and ready for use without any preparation steps before administration. This can save critical time in emergencies where urokinase needs to be administered quickly. The solution form might have a shorter shelf life than the powder form and require specific storage conditions such as refrigeration to maintain its efficacy over time.

Application: Expanding application of urokinase in hospitals as a pivotal therapeutic agent

Hospitals represent a significant application segment for urokinase due to the high incidence of conditions necessitating thrombolytic therapy, such as pulmonary embolism and acute myocardial infarction. The need-based preference leans significantly towards emergency care and acute management of life-threatening conditions. Hospitals require a consistent and reliable supply of urokinase to meet the immediate needs of patients in critical care. Research institutions use urokinase predominantly for scientific exploration into its existing applications and potential new therapeutic uses. The preference here is for high-purity, research-grade urokinase that can be used in controlled experiments to study its pharmacodynamics and pharmacokinetics or to explore its use in treating conditions outside its current indications. Specialty clinics, such as those focused on cardiovascular health or chronic diseases, utilize urokinase for targeted therapeutic applications in a non-hospital setting. These clinics prefer urokinase products tailored for outpatient care, requiring stability, ease of administration, and patient-friendly formulation.

Regional Insights

The Urokinase market in the Americas, notably the United States, shows significant growth potential due to the high prevalence of cardiovascular diseases and lifestyle-related conditions that lead to thrombosis. Advanced healthcare infrastructure, coupled with substantial investments in research and development, supports market expansion in this region. In the EMEA region, Europe stands out as a significant market for Urokinase due to its well-established healthcare system and an increasing patient pool requiring thrombolytic therapy. Initiatives for stroke prevention and awareness about the treatments available for thrombosis are factors propelling the market forward. The Middle East and Africa, while emerging markets, show promise due to government initiatives to improve healthcare infrastructure and increase healthcare spending. The Asia Pacific region is projected to be the fastest-growing market for Urokinase, driven by rapidly developing healthcare systems, increased healthcare expenditures, and a rising prevalence of diseases associated with blood clots. Countries, including China and India, are at the forefront, with China being a significant player due to its large-scale production and favorable government policies for biopharmaceuticals. Increasing awareness about thrombotic diseases and their treatments and improvements in healthcare infrastructure contribute to the market's growth in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Urokinase Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Urokinase Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Urokinase Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BBT Biotech GmbH, Cerbios-Pharma SA, Echelon Biosciences, Ilex Life Sciences LLC, JCR Pharmaceuticals Co., Ltd., Jiangsu Aidea Pharmaceutical Co., Ltd, Jiangxi Haoran Bio-pharma Co., Ltd., Kraeber & Co GmbH, Merck KGaA, Microbix Biosystems Inc., Midas Pharma GmbH, Pfizer Inc., Syner-Med Pharmaceuticals, Taj Pharmaceuticals Ltd., Thermo Fisher Scientific Inc., VWR International, LLC, Wanhua Biochem Products Co. Ltd., and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Urokinase Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Urokinase Powder
    • Urokinase Solution
  • Dose Strength
    • 250000 Unit
    • 5000 Unit
  • Indication
    • Catheter Clearance
    • Coronary Artery Thrombosis
    • Deep Vein Thrombosis
    • Pulmonary Embolism
  • Application
    • Hospital
    • Research Institutions
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Urokinase Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Urokinase Market?

3. What are the technology trends and regulatory frameworks in the Urokinase Market?

4. What is the market share of the leading vendors in the Urokinase Market?

5. Which modes and strategic moves are suitable for entering the Urokinase Market?

Show more
Product Code: MRR-0355054AC506

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of pulmonary embolism and coronary artery thrombosis worldwide=
      • 5.1.1.2. Supportive government approvals for urokinase-based medications
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of drug development and availability of alternatives
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development to improve the applicability of urokinase
      • 5.1.3.2. Adoption of advanced drug delivery systems to enhance the effectiveness of urokinase-based treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects associated with urokinase-based drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Significant preference towards urokinase powder due to superior shelf life
    • 5.2.2. Application: Expanding application of urokinase in hospitals as a pivotal therapeutic agent
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Urokinase Market, by Type

  • 6.1. Introduction
  • 6.2. Urokinase Powder
  • 6.3. Urokinase Solution

7. Urokinase Market, by Dose Strength

  • 7.1. Introduction
  • 7.2. 250000 Unit
  • 7.3. 5000 Unit

8. Urokinase Market, by Indication

  • 8.1. Introduction
  • 8.2. Catheter Clearance
  • 8.3. Coronary Artery Thrombosis
  • 8.4. Deep Vein Thrombosis
  • 8.5. Pulmonary Embolism

9. Urokinase Market, by Application

  • 9.1. Introduction
  • 9.2. Hospital
  • 9.3. Research Institutions
  • 9.4. Specialty Clinics

10. Americas Urokinase Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Urokinase Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Urokinase Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Strategic Alliance Revives Kinlytic: A Milestone in Thrombolytic Therapy
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio
Show more
Product Code: MRR-0355054AC506

LIST OF FIGURES

  • FIGURE 1. UROKINASE MARKET RESEARCH PROCESS
  • FIGURE 2. UROKINASE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL UROKINASE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. UROKINASE MARKET DYNAMICS
  • FIGURE 7. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL UROKINASE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL UROKINASE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. UROKINASE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. UROKINASE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. UROKINASE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL UROKINASE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL UROKINASE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE POWDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE POWDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE SOLUTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE SOLUTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL UROKINASE MARKET SIZE, BY 250000 UNIT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL UROKINASE MARKET SIZE, BY 250000 UNIT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL UROKINASE MARKET SIZE, BY 5000 UNIT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL UROKINASE MARKET SIZE, BY 5000 UNIT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL UROKINASE MARKET SIZE, BY CATHETER CLEARANCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL UROKINASE MARKET SIZE, BY CATHETER CLEARANCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL UROKINASE MARKET SIZE, BY CORONARY ARTERY THROMBOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL UROKINASE MARKET SIZE, BY CORONARY ARTERY THROMBOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL UROKINASE MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL UROKINASE MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL UROKINASE MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL UROKINASE MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL UROKINASE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL UROKINASE MARKET SIZE, BY HOSPITAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL UROKINASE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL UROKINASE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL UROKINASE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL UROKINASE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC UROKINASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC UROKINASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 322. SOUTH AFRICA UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 325. SPAIN UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. SPAIN UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 329. SPAIN UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 330. SPAIN UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 331. SPAIN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 332. SPAIN UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 333. SWEDEN UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 334. SWEDEN UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 337. SWEDEN UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 338. SWEDEN UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 339. SWEDEN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 340. SWEDEN UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 342. SWITZERLAND UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 346. SWITZERLAND UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. SWITZERLAND UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 349. TURKEY UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. TURKEY UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 353. TURKEY UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 354. TURKEY UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 355. TURKEY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 356. TURKEY UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 362. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 363. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 364. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 365. UNITED KINGDOM UROKINASE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 366. UNITED KINGDOM UROKINASE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 367. UNITED KINGDOM UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2023 (USD MILLION)
  • TABLE 368. UNITED KINGDOM UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2024-2030 (USD MILLION)
  • TABLE 369. UNITED KINGDOM UROKINASE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 370. UNITED KINGDOM UROKINASE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 371. UNITED KINGDOM UROKINASE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 372. UNITED KINGDOM UROKINASE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 373. UROKINASE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 374. UROKINASE MARKET, FPNV POSITIONING MATRIX, 2023
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!